Pulmonology Funding: Addition to Primary List

Research Grants

Restless Legs Syndrome Foundation (RLS Foundation)

24-Jan-25

$100,000USD

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

11-Feb-25

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

11-Feb-25

$700,000USD

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 – Clinical Trials Not Allowed)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

11-Feb-25

Catalyze: Product Definition – Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

11-Feb-25

Catalyze Product Definition – Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

11-Feb-25